Advanced search
Publication Cover
Infectious Diseases Volume 48, 2016 - Issue 10
Submit an article Journal homepage
249
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Treatment efficacy of Ampicillin/Sulbactam in comparison to alternative beta-lactams for severe Acinetobacter baumannii infections

Kirsten BuseyDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA;
,
Jason FerreiraDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA;
,
Petra AldridgeCenter for Health Equity and Quality Research, University of Florida Health Jacksonville, Jacksonville, FL, USA;
,
Donald JohnsonDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA;
,
Nilmarie GuzmanDepartment of Medicine, Division of Infectious Disease, University of Florida Health Jacksonville, Jacksonville, FL, USA
&
Christopher A. JankowskiDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA; Correspondence[email protected]
Pages 775-777 | Received 13 Apr 2016, Accepted 18 May 2016, Published online: 08 Jul 2016

References

  • Lin HS, Lee MH, Cheng CW, et al. Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus–Acinetobacter baumannii complex. Infect Dis (Lond). 2015;47:370–378.
  • Centers for Disease Control and Prevention and National Healthcare Safety Network. Multidrug-Resistant organism and clostridium difficile infection (MDRO/CDI) module. January 2016; [cited 2016 Feb 28]. Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf
  • Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis. 2010;51:79–84.
  • Chan JD, Graves JA, Dellit TH. Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. J Intensive Care Med. 2010;25:343–348.
  • Wood GC, Hanes SD, Croce MA, et al. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis. 2002;34:1425–1430.
  • Koulenti D, Rello J. Gram-negative bacterial pneumonia: aetiology and management. Curr Opin Pulm Med. 2006;12:198–204.
  • Housman ST, Hagihara M, Nicolau DP, et al. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2013;68:2296–2304.
  • Betrosian AP, Frantzeskaki F, Xanthaki A, et al. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scand J Infect Dis. 2007;39:38–43.
  • Betrosian AP, Frantzeskaki F, Xanthaki A, et al. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. J Infect. 2008;56:432–436.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.